These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

125 related articles for article (PubMed ID: 27538783)

  • 21. Closing the access barrier for effective anti-malarials in the private sector in rural Uganda: consortium for ACT private sector subsidy (CAPSS) pilot study.
    Talisuna AO; Daumerie PG; Balyeku A; Egan T; Piot B; Coghlan R; Lugand M; Bwire G; Rwakimari JB; Ndyomugyenyi R; Kato F; Byangire M; Kagwa P; Sebisubi F; Nahamya D; Bonabana A; Mpanga-Mukasa S; Buyungo P; Lukwago J; Batte A; Nakanwagi G; Tibenderana J; Nayer K; Reddy K; Dokwal N; Rugumambaju S; Kidde S; Banerji J; Jagoe G
    Malar J; 2012 Oct; 11():356. PubMed ID: 23107021
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The impact of the private sector co-payment mechanism (PSCM) on the private market for ACT in Nigeria: results of the 2018 cross-sectional outlet and household market surveys.
    Edwards HM; Sarwar R; Mahmud P; Emmanuel S; Maxwell K; Tibenderana JK
    Malar J; 2022 Feb; 21(1):42. PubMed ID: 35151332
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Effect of the Affordable Medicines Facility--malaria (AMFm) on the availability, price, and market share of quality-assured artemisinin-based combination therapies in seven countries: a before-and-after analysis of outlet survey data.
    Tougher S; ; Ye Y; Amuasi JH; Kourgueni IA; Thomson R; Goodman C; Mann AG; Ren R; Willey BA; Adegoke CA; Amin A; Ansong D; Bruxvoort K; Diallo DA; Diap G; Festo C; Johanes B; Juma E; Kalolella A; Malam O; Mberu B; Ndiaye S; Nguah SB; Seydou M; Taylor M; Rueda ST; Wamukoya M; Arnold F; Hanson K
    Lancet; 2012 Dec; 380(9857):1916-26. PubMed ID: 23122217
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Progress towards malaria elimination in the Greater Mekong Subregion: perspectives from the World Health Organization.
    Manzoni G; Try R; Guintran JO; Christiansen-Jucht C; Jacoby E; Sovannaroth S; Zhang Z; Banouvong V; Shortus MS; Reyburn R; Chanthavisouk C; Linn NYY; Thapa B; Khine SK; Sudathip P; Gopinath D; Thieu NQ; Ngon MS; Cong DT; Hui L; Kelley J; Valecha NNK; Bustos MD; Rasmussen C; Tuseo L
    Malar J; 2024 Mar; 23(1):64. PubMed ID: 38429807
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The malaria testing and treatment market in Kinshasa, Democratic Republic of the Congo, 2013.
    ; Mpanya G; Tshefu A; Likwela JL
    Malar J; 2017 Feb; 16(1):94. PubMed ID: 28241832
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Private sector role, readiness and performance for malaria case management in Uganda, 2015.
    ; Kaula H; Buyungo P; Opigo J
    Malar J; 2017 May; 16(1):219. PubMed ID: 28545583
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Challenges encountered by local health volunteers in early diagnosis and prompt treatment of malaria in Myanmar artemisinin resistance containment zones.
    Nyunt MH; Aye KM; Kyaw KT; Han SS; Aye TT; Wai KT; Kyaw MP
    Malar J; 2016 Jun; 15():308. PubMed ID: 27267877
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Access to quality-assured artemisinin-based combination therapy and associated factors among clients of selected private drug outlets in Uganda.
    Ocan M; Nakalembe L; Otike C; Mordecai T; Birungi J; Nsobya S
    Malar J; 2024 Apr; 23(1):128. PubMed ID: 38689257
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Spatial distribution, work patterns, and perception towards malaria interventions among temporary mobile/migrant workers in artemisinin resistance containment zone.
    Wai KT; Kyaw MP; Oo T; Zaw P; Nyunt MH; Thida M; Kyaw TT
    BMC Public Health; 2014 May; 14():463. PubMed ID: 24884534
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The malaria testing and treatment landscape in Kenya: results from a nationally representative survey among the public and private sector in 2016.
    ; Musuva A; Ejersa W; Kiptui R; Memusi D; Abwao E
    Malar J; 2017 Dec; 16(1):494. PubMed ID: 29268789
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Insights following change in drug policy: a descriptive study for antimalarial prescription practices in children of public sector health facilities in Jharkhand state of India.
    Mishra N; Gupta R; Singh S; Rana R; Shahi B; Das MK; Anvikar AR; Valecha N
    J Vector Borne Dis; 2013 Dec; 50(4):271-7. PubMed ID: 24499849
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The malaria testing and treatment landscape in the southern Lao People's Democratic Republic (PDR).
    ; Phanalasy S
    Malar J; 2017 Apr; 16(1):169. PubMed ID: 28438155
    [TBL] [Abstract][Full Text] [Related]  

  • 33. A cross-sectional study of the availability and price of anti-malarial medicines and malaria rapid diagnostic tests in private sector retail drug outlets in rural Western Kenya, 2013.
    Kioko U; Riley C; Dellicour S; Were V; Ouma P; Gutman J; Kariuki S; Omar A; Desai M; Buff AM
    Malar J; 2016 Jul; 15(1):359. PubMed ID: 27406179
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Towards subsidized malaria rapid diagnostic tests. Lessons learned from programmes to subsidise artemisinin-based combination therapies in the private sector: a review.
    Lussiana C
    Health Policy Plan; 2016 Sep; 31(7):928-39. PubMed ID: 25862732
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Molecular surveillance of artemisinin resistance falciparum malaria among migrant goldmine workers in Myanmar.
    Nyunt MH; Wang B; Aye KM; Aye KH; Han JH; Lee SK; Han KT; Htut Y; Han ET
    Malar J; 2017 Mar; 16(1):97. PubMed ID: 28249583
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Geographic expansion of artemisinin resistance.
    Müller O; Lu GY; von Seidlein L
    J Travel Med; 2019 Jun; 26(4):. PubMed ID: 30995310
    [TBL] [Abstract][Full Text] [Related]  

  • 37. K13 mutations and pfmdr1 copy number variation in Plasmodium falciparum malaria in Myanmar.
    Win AA; Imwong M; Kyaw MP; Woodrow CJ; Chotivanich K; Hanboonkunupakarn B; Pukrittayakamee S
    Malar J; 2016 Feb; 15():110. PubMed ID: 26911145
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Monitoring antimalarial drug efficacy in the Greater Mekong Subregion: an overview of in vivo results from 2008 to 2010.
    Bustos MD; Wongsrichanalai C; Delacollette C; Burkholder B
    Southeast Asian J Trop Med Public Health; 2013; 44 Suppl 1():201-30; discussion 306-7. PubMed ID: 24159833
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Evaluation of the behaviour change communication and community mobilization activities in Myanmar artemisinin resistance containment zones.
    Nyunt MH; Aye KM; Kyaw MP; Wai KT; Oo T; Than A; Oo HW; Phway HP; Han SS; Htun T; San KK
    Malar J; 2015 Dec; 14():522. PubMed ID: 26697850
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Mobility dynamics of migrant workers and their socio-behavioral parameters related to malaria in Tier II, Artemisinin Resistance Containment Zone, Myanmar.
    Hlaing T; Wai KT; Oo T; Sint N; Min T; Myar S; Lon KN; Naing MM; Tun TT; Maung NL; Galappaththy GN; Thimarsan K; Wai TT; Thaung LN
    BMC Public Health; 2015 Sep; 15():886. PubMed ID: 26370297
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.